AU2003233881A1 - Method of forming iron hydroxypyrone compounds - Google Patents

Method of forming iron hydroxypyrone compounds

Info

Publication number
AU2003233881A1
AU2003233881A1 AU2003233881A AU2003233881A AU2003233881A1 AU 2003233881 A1 AU2003233881 A1 AU 2003233881A1 AU 2003233881 A AU2003233881 A AU 2003233881A AU 2003233881 A AU2003233881 A AU 2003233881A AU 2003233881 A1 AU2003233881 A1 AU 2003233881A1
Authority
AU
Australia
Prior art keywords
forming iron
iron hydroxypyrone
hydroxypyrone compounds
compounds
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003233881A
Other languages
English (en)
Inventor
Michael Arthur Stockham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitra Pharmaceuticals Ltd
Original Assignee
Vitra Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitra Pharmaceuticals Ltd filed Critical Vitra Pharmaceuticals Ltd
Publication of AU2003233881A1 publication Critical patent/AU2003233881A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2003233881A 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds Abandoned AU2003233881A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
GB0211500.4 2002-05-18
PCT/GB2003/001956 WO2003097627A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds

Publications (1)

Publication Number Publication Date
AU2003233881A1 true AU2003233881A1 (en) 2003-12-02

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003233881A Abandoned AU2003233881A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds

Country Status (11)

Country Link
US (1) US7459569B2 (enrdf_load_html_response)
EP (1) EP1506183B1 (enrdf_load_html_response)
AT (1) ATE352547T1 (enrdf_load_html_response)
AU (1) AU2003233881A1 (enrdf_load_html_response)
BE (1) BE2016C041I2 (enrdf_load_html_response)
CA (1) CA2483067C (enrdf_load_html_response)
DE (1) DE60311456T2 (enrdf_load_html_response)
ES (1) ES2283771T3 (enrdf_load_html_response)
FR (1) FR16C0033I2 (enrdf_load_html_response)
GB (1) GB0211500D0 (enrdf_load_html_response)
WO (1) WO2003097627A1 (enrdf_load_html_response)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
EP2125847B1 (en) 2007-02-06 2015-06-17 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) * 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
CN109311837B (zh) * 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由氢氧化亚铁产生麦芽酚铁组合物的方法
CN109790138B (zh) * 2016-03-31 2023-08-18 英国神盾Tx股份有限公司 由配体修饰的和配体涂覆的氢氧化铁生产麦芽酚铁组合物的方法
JP7033546B2 (ja) * 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド 元素鉄からマルトール第二鉄組成物を生成するための方法
KR102341615B1 (ko) 2016-03-31 2021-12-21 실드 티엑스 (유케이) 리미티드 암 및 종양의 치료 또는 예방에서 사용하기 위한 제2철 말톨 조성물
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
DE1518098A1 (de) * 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
SE322866B (enrdf_load_html_response) * 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) * 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
CY1501A (en) * 1982-03-24 1990-08-03 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or-4-one derivatives
GR78491B (enrdf_load_html_response) 1982-03-24 1984-09-27 Nat Res Dev
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
WO1996041627A2 (en) 1995-06-10 1996-12-27 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
BE2016C041I2 (enrdf_load_html_response) 2022-08-09
EP1506183B1 (en) 2007-01-24
US20050250754A1 (en) 2005-11-10
WO2003097627A1 (en) 2003-11-27
DE60311456T2 (de) 2007-11-15
CA2483067C (en) 2011-04-26
US7459569B2 (en) 2008-12-02
CA2483067A1 (en) 2003-11-27
FR16C0033I1 (enrdf_load_html_response) 2016-09-23
EP1506183A1 (en) 2005-02-16
GB0211500D0 (en) 2002-06-26
DE60311456D1 (de) 2007-03-15
ES2283771T3 (es) 2007-11-01
FR16C0033I2 (fr) 2018-01-19
ATE352547T1 (de) 2007-02-15

Similar Documents

Publication Publication Date Title
BE2016C041I2 (enrdf_load_html_response)
AU2001281028A1 (en) Dilute acid/metal salt hydrolysis of lignocellulosics
EP2272825A3 (en) N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
EP1380564A4 (en) BINAPHTOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
MXPA03009565A (es) Derivado de acido carboxilico y una sal del mismo.
AU2002251481A1 (en) Carboxylic acid derivative and salt thereof
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
MXPA01002392A (es) Metodos y composiciones acidificadas para reducir la corrosion en las superficies de metal y la precipitacion del sulfuro.
CA2455539A1 (en) Pig growth enhancer and pig growth enhancing method
WO2003088956A8 (en) Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
WO2003062344A3 (en) Acidizing and scale treatment of subterranean formation
PT1543826E (pt) Solução aquosa concentrada de ambroxol
WO2004095921A3 (en) Sporicidal composition
AU2002308031A1 (en) Enteric ketoacid salts and amino acids
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
AU2001256324A1 (en) Process for the preparation of alkaline earth salts of d-pantothenic acid
AU2002218164A1 (en) Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
NZ514653A (en) Process for producing an amide compound by reacting a compound with an amino group with a polyaminocarboxylic acid anhydride
IL157402A0 (en) Method for producing d-pantothenic acid and/or salts therefor as an additive for animal feed
WO2002066663A3 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
HRP20031004A2 (en) Method for producing an essentially chlorite-free,stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
HUP0303304A3 (en) Method for producing d-pantothenic acid and/or salts thereof as an additive for animal feed
EP1245535A3 (en) An aqueous solution containing hydroxylamine salt and storing method thereof
MY134147A (en) Method for stoping hysteresis
MXPA04000513A (es) Proceso para la preparacion de 4-metilamino-4-fenilpiperidina.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase